This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,214.98, is for the delivery of Quillivant XR 25 mg/5 ml suspension in 180 ml bottles. The contract has an ultimate completion date of December 27, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated with a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/27/25, 9:48 AM